Investor Relations
Recent Releases
Aug 3, 2010
MAP Pharmaceuticals Reports Second Quarter of 2010 Financial Results
Jul 27, 2010
MAP Pharmaceuticals to Present at Upcoming Healthcare Conferences
Jul 13, 2010
MAP Pharmaceuticals Announces Results from LEVADEX Pharmacokinetics Trial in Smokers
Events & Presentations
Sep 15, 2010 at 2:05 PM ET
Stifel Nicolaus 2010 Healthcare Conference
Stock Information
| NASDAQ:MAPP
$11.76 |
+ 0.31 |
| Sep 3, 2010 | 4:00 PM ET |
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Information provided by eSignal.